is a pivotal event in the invasion and metastasis of cancer cells. Psoralea corylifolia L. (PC) inhibits the proliferation of various cancer cells. However, its possible role in EMT has not been identified. In the present study, we examined the effects of an aqueous extract of Psoralea corylifolia L. (PCAE), a typical medicinal decoction, on the EMT. Lipopolysaccharide (LPS) induced EMT-like phenotypic changes, enhancing cell migration and invasion. However, PCAE markedly reduced the expression of the LPS-induced EMT markers, including N-cadherin and vimentin, and increased the expression of β-catenin. PCAE also inhibited cell migration and invasion in vitro. The effects of PCAE on the LPS-induced EMT were mediated by the inactivation of the NF-κB-SNAIL signaling pathway. The results provide new evidence that PCAE suppresses cancer cell invasion and migration by inhibiting EMT. Therefore, PCAE is a potentially effective dietary chemopreventive agent for malignant tumors since it inhibits metastasis.
Introduction
Cancer is the cause of 25% of mortalities in developed countries (1) . The prognosis of patients with advanced cancer is associated with the degree of aggressive metastasis (2, 3) . It is imperative to understand the mechanisms involved in the metastasis of cancer since there are limited effective therapies available once the cancer has spread (3) (4) (5) . The process of cancer metastasis appears to be regulated by a variety of gene products, however, the precise mechanisms of tumor cell dissemination are poorly understood (6, 7) . The epithelial-mesenchymal transition (EMT), which has been recognized for several decades as a fundamental process of embryogenesis, may be involved in many pathological processes, particularly cancer progression. During the EMT of cancer cells in situ, epithelial cell layers lose their polarity and their cell-cell contacts, and then undergo a marked remodeling of the cytoskeleton. The expression of proteins that promote cell-cell contact, such as E-cadherin and β-catenin, may be lost, and the cells may acquire mesenchymal markers, such as vimentin, fibronectin and N-cadherin, enhancing their ability for cell migration and invasion, which are pivotal events in the initial step of metastasis. Therefore, investigators have focused on inhibiting the EMT of cancer cells as a new therapeutic strategy to prevent cancer metastasis.
Cancer chemoprevention using natural compounds, known as 'dietary chemoprevention', prevents or suppresses the development of cancer, and is attracting interest as a cancer therapy. Understanding the molecular mechanisms of dietary chemoprevention is important for the safe application of these compounds in populations of patients at a high risk of cancer, as well as the development of novel treatment regimens for cancer patients.
Psolarea corylifolia L. (PC), commonly known as 'Boh-Gol-Zhee' in Korea, is used in traditional Ayurvedic and Chinese medicine. Six compounds (bakuchiol, psoralen, isopsoralen, corylifolin, corylin and psoralidin) are the major components of PC extract, and they possess significant antibacterial, antifungal, antioxidant, antitumor, estrogenic and immunomodulatory properties (8) . It has been reported that whole extracts of PC, in organic solvents such as methanol, ethanol and chloroform, inhibit the proliferation of cancer cells, although the mechanism of action remains to be elucidated (9) (10) (11) .
In the present study, we hypothesized that an aqueous extract of Psoralea corylifolia L. (PCAE), a typical medicinal decoction, is an effective inhibitor of EMT during cancer progression, and may therefore be used as a dietary chemopreventive agent for malignant tumors. We reported that PCAE significantly inhibited the invasion and migration of various cancer cells during the LPS-induced EMT by downregulating 
Materials and methods

Materials and reagents.
The PC used in the present study was kindly supplied by Professor Jung-Hye Choi (Kyung Hee university). Aqueous extraction procedures were performed by boiling 100 g PC in 500 ml distilled water for 30 min and then filtering using Whatman filter paper no. 2 (Advantec, Tokyo, Japan). Subsequently, the filtrates were combined and evaporated under a vacuum and lyophilized with a freeze dryer (Ilshine Laboratory, Suwon, korea Colony-forming assay. Single-cell suspensions of 5x10 3 cells were seeded in a 6-well plate and allowed to attach for 24 h at 37˚C in culture medium. The cells were then treated with 100 or 1,000 µM PCAE. After 10 days, the colonies were fixed with 100% methanol for 10 min at room temperature and stained with 0.1% crystal violet. Plates were washed with phosphate-buffered saline (PBS) and images were captured.
Immunofluorescence staining. MDA-MB231 cells were grown in 4-chamber slides in serum-free medium, and were treated with LPS (5 µg/ml) or co-treated with LPS (5 µg/ml) and PVAE (100 µM). After 24-h incubation, the cells were fixed with 4% paraformaldehyde at 4˚C. The cells were washed with PBS containing 0.1% BSA and incubated with anti-N-cadherin antibody for 1 h followed by 1 h incubation with fluorescence-tagged secondary antibody, then counterstained with 4' ,6-diamidino-2-phenylindole (DAPI) for 5 min. Cell images were captured at a magnification of x400 on a Leica fluorescence microscope.
Cell migration assay. Migration was assessed by a woundhealing assay. The cells were seeded at 2x10 4 MDA-MB231 and SkoV-3 cells/well and were cultured for 24 h. After scraping the cell monolayer with a sterile micropipette tip, the wells were washed with PBS, and treated with LPS (5 µg/ml) or co-treated with LPS (5 µg/ml) and PCAE (100 µM). The first image of each scratch was obtained at time zero. At 24 h, each scratch was examined and captured at the same location and the healed area was measured.
Transwell invasion assay. The invasion of tumor cells was assessed in Transwell chambers equipped with 8-µm pore size, 6.5 mm diameter polyvinylpyrrolidone-free polycarbonated membranes that were coated with 1 mg/ml fibronectin. The cells were seeded onto the upper wells at a concentration of 1x10 5 and MDA-MB231 and SkoV-3 cells/well were cultured for 24 h following treatment with LPS (5 µg/ml) or co-treatment with LPS (5 µg/ml) and PCAE (100 µM). The bottom chambers of the Transwell were filled with conditioned medium. After incubation for 24 h, the cells were fixed with 100% methanol for 10 min at room temperature, stained with 0.1% crystal violet and counted under a light microscope.
Western blotting. The MDA-MB231 and SkoV-3 cells were treated with LPS (5 µg/ml) or co-treated with LPS (5 µg/ml) and PVAE (100 µM) for 24 h. After lysing the cells with rIPA buffer, the proteins were resolved by SDS-PAGE and immunoblotted using primary antibodies such as anti-N-cadherin, anti-β-catenin, anti-vimentin, anti-NF-κB p65 subunit, anti-Snail and anti-β-actin antibody. Following treatment with appropriate secondary antibodies, the immunoreactive bands were visualized using a standard ECL method.
Statistical analysis.
The results are presented as mean ± SE. Statistical comparisons between groups were carried out using one-way ANoVA followed by the Student's t-test.
Results
PCAE inhibits the growth of human cancer cell in vitro.
We initially examined the effects of PCAE on the proliferation of two human metastatic cancer cell lines, MDA-MB231 (breast cancer cells) and SkoV-3 (ovarian cancer cells). The cancer cell lines were treated for 24 h with various concentrations of PCAE and cell viability was measured with a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. As shown in Fig. 1A , cell proliferation was inhibited by PCAE in a dose-dependent manner, although a different IC 50 (the drug concentration that causes 50% growth inhibition) was observed for each cell line (417±7 µg/ml for MDA-MB231 and 690±4 µg/ml for SkoV-3). The long-term effects of PCAE were determined with a colony-forming assay. MDA-MB231 and SkoV-3 cells were cultured with or without PCAE for 10-15 days. A PCAE concentration of 100 µg/ml had no significant effect on the cells, whereas 1,000 µg/ml PCAE almost completely inhibited colony formation (Fig. 1B and C) . Therefore, we considered 100 µg/ml PCAE a suitable dose for subsequent experiments.
PCAE inhibits LPS-induced cell migration and invasion during EMT.
Chen et al have reported that, LPS (5 µg/ml) independently triggers the EMT process (12) . We investigated the effects of PCAE on cell migration and invasion to verify that PCAE inhibits LPS-induced EMT since the EMT is associated with enhanced tumor progression. Two cancer cell lines were treated with LPS-alone, a combination of LPS plus PCAE or PCAE-alone, and were monitored with a wound-healing assay and a fibronectin-based Transwell invasion assay. The LPS-treated cancer cells exhibited a ≥1.2-fold increase in migration, whereas treatment with 100 µg/ml PCAE inhibited this LPS-induced migration by 60% ( Fig. 2A and B) . We also examined whether PCAE inhibits the LPS-induced invasiveness of cancer cells. Following treatment with LPS-alone, the number of invasive cells significantly increased compared with the untreated cells (≥1.6-fold increase). However, the number of invasive cells was significantly reduced in the cells treated with the combination of LPS plus PCAE (Fig. 3A and B) . These data suggested that PCAE inhibited the effect of LPS, thus increasing the invasiveness of human cancer cells, as occurs for the EMT.
PCAE regulates the expression of EMT-related proteins in human cancer cells.
We investigated the expression of EMT-related proteins, such as N-cadherin, β-catenin and vimentin, to clarify the effects of PCAE on the LPS-induced EMT. The protein expression was measured using western blotting and quantitatively analyzed ( Fig. 4A and B) . The expression of β-catenin was significantly downregulated, whereas that of N-cadherin and vimentin was upregulated in the LPS-treated cancer cells compared with their expression in the controls. However, PCAE reversed the LPS-induced EMT by reinducing the expression of β-catenin, and inhibiting N-cadherin and vimentin expression. We also examined the expression of N-cadherin in cancer cells with fluorescent imaging (Fig. 4C) . Consistent with the western blotting results, N-cadherin was highly expressed after LPS treatment, although its expression decreased significantly after PCAE treatment. The western blotting and fluorescent imaging results suggested that PCAE inhibits the cellular EMT.
NF-κB-SNAIL signaling is required to alter EMT marker expression.
Previous findings showed numerous drugs inhibit the invasion and migration of cancer cells by suppressing NF-κB expression (13, 14) . Therefore, the NF-κB signaling pathway is critically involved in the acquisition of the EMT, mediated by SNAIL, a transcription factor directly downstream from NF-κB. To determine whether the effect of PCAE described above is associated with the inhibition of the NF-κB-SNAIL pathway, we investigated the expression of the NF-κB p65 subunit and SNAIL protein using western blotting and quantitative analysis (Fig. 5A and B) . As shown in Fig. 5 , LPS significantly upregulated the expression of NF-κB p65 and SNAIL protein, with the exception of NF-κB p65 in MDA-MB231, which reduced the expression of E-cadherin and β-catenin, and increased the expression of N-cadherin and vimentin as identified in previous western blotting results. However, PCAE inhibited this effect, counteracting the effect of LPS on NF-κB p65 and SNAIL expression. PCAE even decreased NF-κB p65 and SNAIL expression compared to the control group. These results indicated that PCAE inhibits the activation of NF-κB-SNAIL, which plays a critical role in the EMT.
Discussion
The EMT is the best-known example of the changes that occur in the patterns and functions of cancer cells (15) . Epithelial cells acquire mesenchymal fibroblast-like phenotypes, with reduced cell-cell adhesion, loss of polarity and increased migration and invasiveness (16) . As a prerequisite for EMT, cells lose their cell-cell junctions via different mechanisms, including loss-of-function mutations in the cadherins or catenins, or the upregulation of proteases that cleave the cadherins (17) . The EMT is considered to be a significant step in the invasive cascade, facilitating the migration of tumor cells from their site of origin and their dissemination to distant tissues (18) . When the tumor reaches the dedifferentiated stage, at which single cells are disseminated, metastatic spread increases, resulting in a poor prognosis. Therefore, blocking or reversing this process with exogenous agents is a promising therapeutic strategy to limit cancer spread.
In a previous study, LPS induced the EMT of cancer cells, increasing their invasiveness and migration, which enhanced the metastasis of breast cancer cells to the lung (19) . In the present study, we have shown that various cancer cells can be induced by LPS to undergo a stimulated EMT, reducing β-catenin expression, and increasing N-cadherin and vimentin expression. PCAE inhibits the action of LPS in inducing EMT, reversing the altered expression of proteins associated with cell invasion and migration. We also found that NF-κB-SNAIL signaling is required for the LPS-induced EMT in various cancer cells, which clarifies the mechanism by which PCAE inhibits cancer cell metastasis.
PC has been widely used in Ayurvedic and Chinese medicine as a cardiac tonic, vasodilator and antitumor, antibacterial, cytotoxic and antihelminthic agent (8) . Extracts of PC produced with various solvents, such as methanol, ethanol and chloroform, have significant antitumor activity since they inhibit DNA replication, the induction of hypoxia-inducible factor-1 activation by hypoxia, mitochondrial complex I and proteasomal activities (11, 20, 21) . However, PC has not been associated with cancer metastasis via the EMT, although its strong antitumor effects have been reported. To the best of our knowledge, this is the first study to demonstrate that the antimetastatic effects of PC are associated with the EMT in cultured human cancer cells. Therefore, our results suggest a new dietary chemopreventive role for PC in inhibiting the progression of cancer metastasis.
In the present study, we have shown that PCAE inhibits the LPS-induced EMT, and thus cell migration and invasion, which result from the dysregulation of cell-cell adhesion proteins and the expression of EMT-related proteins, such as N-cadherin. Cadherins are transmembrane glycoproteins that mediate Ca 2+ -dependent cell-cell adhesion (22) . N-cadherin is associated with the heightened invasive potential of cancer cells. N-cadherin is typically expressed by mesenchymal cells, is overexpressed in some cancer cells and correlates with cell invasiveness (23) . Therefore, the gain of N-cadherin expression in cancer cells has a functional significance in cancer progression and metastasis (24) . PCAE also regulates the expression of other EMT-related proteins, such as β-catenin and vimentin, inhibiting cell migration and invasion. β-catenin is a transcription factor in the WNT signaling pathway and is involved in the regulation of cell adhesion. It is typically most abundant in epithelial-like cells (25, 26) . Vimentin is an intermediate filament typically found in non-epithelial and mesenchymal cells (27) . When drugs inhibit the EMT of cancer cells, β-catenin expression increases and vimentin expression decreases.
Our results suggest that the mechanism of action of Psoralea corylifolia L. involves the suppression of NF-κB-SNAIL signaling. NF-κB is a structurally conserved family of dimeric transcription factors that play pivotal roles in maintaining the invasive phenotype and promoting the metastasis of cancer cells (28) (29) (30) . It is also an essential central mediator of the EMT since the SNAIL transcription factor plays a critical role in the EMT and its expression is directly induced by NF-κB (31) . The expression of SNAIL mrNA at the EMT may be reversed by the inhibition of NF-κB, which is the upstream regulator of SNAIL expression at the EMT (32). our results support previous findings that NF-κB is the upstream regulator of SNAIL and indirectly mediates the EMT, explaining the inhibition of tumor progression by Psoralea corylifolia L. and PCAE.
In conclusion, we have shown that PCAE inhibits tumor cell invasion and migration, which are associated with the EMT during tumor progression, possibly by inhibiting the activation of NF-κB-SNAIL signaling and regulating the expression of important downstream EMT markers, such as E-cadherin, β-catenin, N-cadherin and vimentin. Although further in vivo studies are required to determine the potential utility of PCAE, inhibiting the migration and invasion of tumor cells, as a cancer therapy, we suggest that PCAE is an effective dietary chemopreventive agent for malignant tumors because it inhibits metastasis. 
